Cleerly ISCHEMIA vs Eko Analysis Software

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Cleerly ISCHEMIA
by Cleerly
VS
Eko Analysis Software
by Eko Devices

AI Verdict

Cleerly ISCHEMIA and Eko Analysis Software are adjacent healthcare-AI tools, both assisting in cardiovascular disease diagnosis but through distinct methodologies. Cleerly focuses on advanced CCTA analysis for coronary artery ischemia and plaque characterization, while Eko utilizes digital stethoscopes and ECG for early detection of heart murmurs and atrial fibrillation. Physicians would choose between them based on the specific diagnostic question and the type of data available.

Choose Cleerly ISCHEMIA if…

Choose Cleerly ISCHEMIA if you require a detailed, non-invasive assessment of coronary artery disease and vessel-level ischemia based on CCTA scans. This tool is ideal for refining diagnosis and personalizing treatment plans by providing insights into plaque characteristics, stenosis severity, and estimated fractional flow reserve without invasive procedures.

View Cleerly ISCHEMIA →

Choose Eko Analysis Software if…

Choose Eko Analysis Software if you need an AI-powered assistant for early detection of common cardiovascular conditions during routine physical exams or initial screenings. This software, integrated with digital stethoscopes, is best suited for quickly identifying heart murmurs and atrial fibrillation at the point of care, aiding in timely referrals or further diagnostic steps.

View Eko Analysis Software →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Cleerly ISCHEMIA Eko Analysis Software
Pricing Unknown Freemium with subscription for full features
Deployment Web-based solution Cloud-based
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Cleerly ISCHEMIA Eko Analysis Software
Name Cleerly ISCHEMIA Eko Analysis Software
Primary Use Case / AI Focus AI-enabled CCTA analysis for non-invasive fractional flow reserve (FFR) estimation, vessel-level ischemia likelihood determination, coronary plaque characterization (volume, type, location), and stenosis severity assessment. FDA-cleared AI for heart murmur detection, atrial fibrillation (AFib) detection, and detection of normal sinus rhythm.
Input Data / Device Integration CCTA scans; data transfer via Cleerly Proxy (VPN or virtual appliance) Eko's digital stethoscopes and mobile app; wireless auscultation with Bluetooth-enabled devices
Target Specialties Cardiology, Radiology Cardiology, Emergency Medicine, Internal Medicine
Key Output / Reporting 3D digital models of coronary arteries, comprehensive interactive web-based reports, integration with PowerScribe via API. Recording, playback, and annotation of heart sounds and ECGs; visualization of phonocardiograms (PCG) and ECG tracings; secure cloud-based storage of recordings; PDF reports (requires Eko+ membership).
Company Cleerly Eko Devices

Videos

Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and Eko Analysis Software.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Cleerly ISCHEMIA is designed for non-invasive detection of coronary artery ischemia at a vessel level by analyzing CCTA scans, aiding in personalized diagnosis and treatment planning for heart disease. Eko Analysis Software, conversely, integrates with digital stethoscopes and a mobile app to assist clinicians in the early detection of cardiovascular diseases such as heart murmurs and atrial fibrillation.
Cleerly ISCHEMIA analyzes CCTA (Coronary CT Angiography) scans to provide detailed insights into coronary plaque characteristics, stenosis severity, and ischemia likelihood. Eko Analysis Software processes heart sounds (phonocardiograms) and ECG tracings captured via Eko's digital stethoscopes and mobile app.
Cleerly ISCHEMIA provides AI-enabled CCTA analysis for vessel-level ischemia likelihood, non-invasive fractional flow reserve (FFR) estimation, and comprehensive coronary plaque characterization. Eko Analysis Software offers FDA-cleared AI for the detection of heart murmurs, atrial fibrillation (AFib), and normal sinus rhythm, along with cardiac time interval calculations.
Cleerly ISCHEMIA is primarily utilized within Cardiology and Radiology specialties due to its focus on advanced CCTA analysis for coronary artery disease. Eko Analysis Software is designed for a broader range of specialties, including Cardiology, Emergency Medicine, and Internal Medicine, for point-of-care cardiovascular screening.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Cleerly ISCHEMIA or Eko Analysis Software

Backers

Who funded each tool's parent company.

Cleerly ISCHEMIA

Eko Analysis Software

AI Tool Finder
AI-powered search. Results may not be comprehensive.